Analyst firms · BofA Securities · BDX

BofA Securities BDX price target and rating history

Becton Dickinson and Company (BDX) · Health Care

BofA Securities rates Becton Dickinson and Company (BDX) Neutral with a $190 price target, as of its latest action on May 1, 2025. It has published 3 rating actions on BDX since March 2022, including 1 upgrade and 1 downgrade. Across 6 firms with a BDX price target in the last 12 months, the median target is $191.

Current rating
Neutral
Price target
$190
Median target, all firms
$191
Actions on BDX
3

BofA Securities price target on BDX

$290$240$1902023202420252026
BofA Securities price target on BDX, each point a stated target, March 2022 to May 2025.

Every BofA Securities rating on BDX

How other firms rate BDX

Each firm's latest rating and stated target in the last 12 months.

FirmRatingPrice targetDate
Wells FargoOverweight$242Nov 6, 2026
Wolfe ResearchOutperformOct 20, 2026
UBSBuy$19Jul 28, 2026
Evercore ISIOutperform$180May 4, 2026
Goldman SachsNeutral$167Apr 10, 2026
BarclaysOverweight$202Feb 10, 2026
CitigroupBuy$233Feb 3, 2026

Questions about BofA Securities and BDX

What is BofA Securities's price target for BDX?
BofA Securities's latest stated price target for Becton Dickinson and Company (BDX) is $190, from its action on May 1, 2025.
What is BofA Securities's rating on BDX?
BofA Securities rates BDX Neutral, a neutral rating, as of May 1, 2025.
When did BofA Securities last change its view on BDX?
On May 1, 2025, BofA Securities downgrades to Neutral from Buy, price target $190.
How does BofA Securities's BDX target compare with other analysts?
Across 6 firms with a BDX price target in the last 12 months, the median target is $191.

More BDX rating histories

All BofA Securities ratingsBDX news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.